Sanofi says Lyxumia diabetes drug studies positive

PARIS, Oct 2 (Reuters) - Sanofi's experimental diabetes treatment Lyxumia can slow down the rate at which food passes and can reduce blood sugar levels after a meal when given in combination with other diabetes drugs, the drugmaker said in a statement on Tuesday.

The data from late-stage studies was presented at the European Association for the Study of Diabetes (EASD) congress in Berlin.

(Reporting by Elena Berton; Editing by James Regan)


Messaging: elena.berton.thomsonreuters.com@reuters.net))